-+ 0.00%
-+ 0.00%
-+ 0.00%

Regencell Bioscience replaces auditor Marcum Asia with HTL International

PUBT·04/17/2026 20:16:16
Listen to the news
Regencell Bioscience replaces auditor Marcum Asia with HTL International
  • Regencell Bioscience dismissed Marcum Asia as independent registered public accounting firm, effective April 16, 2026.
  • HTL International was appointed effective April 16, 2026 to audit consolidated financial statements for fiscal year ending June 30, 2026.
  • Marcum Asia audit reports for fiscal 2024 and 2025 carried a going-concern explanatory paragraph.
  • No disagreements or reportable events were cited through April 16, 2026, aside from previously disclosed material weaknesses.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Regencell Bioscience Holdings Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-045171), on April 17, 2026, and is solely responsible for the information contained therein.